Subhash Yadav

Subhash Yadav

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2008
Verified
Journal Article
Closed access
SYSubhash Yadav
Subhash Yadav
RBR Boddula
R Boddula
GGG Genitta
G Genitta
VBV Bhatia
V Bhatia
BBB Bansal
B Bansal
EBE Bhatia
E Bhatia

1 April 2017 in British Journal of Radiology
Verified
Journal Article
Closed access
DSDeepa Singh
Deepa Singh
ACAditi Chopra
Aditi Chopra
MRMudalsha Ravina
Mudalsha Ravina
SKSrikant Kongara
Srikant Kongara
EBEesh Bhatia
Eesh Bhatia
SGSanjay Gambhir
Sanjay Gambhir
Objective:The aim of this study was to evaluate the role of 68Ga-DOTANOC positron emission tomography (PET)/CT scan in localization of culprit lesion for biopsy and required intervention [surgical excision/radiofrequency ablation (RFA)] in patients with long-standing oncogenic osteomalacia (OOM)/tumour-induced osteomalacia.Methods:17 patients (8 males and 9 females) underwent 68Ga-DOTANOC PET/CT scan. The patients referred with clinical and biochemical evidence of hypophosphatemia and raised fibroblast growth factor-23. Qualitative and semi-quantitative parameters were used to identify culprit lesions.Results:68Ga-DOTANOC PET/CT scan revealed 52 lesions in 17 patients, and 37/52 of these lesions were tracer avid. 26/37 lesions were non-specific focal tracer-avid skeletal lesions (fractures or degenerative changes). 11/37 tracer-avid skeletal lesions present in 9 patients (3 lesions in 1 patient and 1 each in rest of the 8 patients) were highly suspicious for culprit lesions in view of high maximum standar...

15 September 2018 in BMC Medical Ethics
Verified
Journal Article
Open access
PDF file
FTFERCAP Multi-Country Research Team
FERCAP Multi-Country Research Team
JKJuntra Karbwang
Juntra Karbwang
NKNut Koonrungsesomboon
Nut Koonrungsesomboon
CTCristina E. Torres
Cristina E. Torres
EJEdlyn B. Jimenez
Edlyn B. Jimenez
SYSubhash Yadav
Subhash Yadav
The use of lengthy, detailed, and complex informed consent forms (ICFs) is of paramount concern in biomedical research as it may not truly promote the rights and interests of research participants. The extent of information in ICFs has been the subject of debates for decades; however, no clear guidance is given. Thus, the objective of this study was to determine the perspectives of research participants about the type and extent of information they need when they are invited to participate in biomedical research. This multi-center, cross-sectional, descriptive survey was conducted at 54 study sites in seven Asia-Pacific countries. A modified Likert-scale questionnaire was used to determine the importance of each element in the ICF among research participants of a biomedical study, with an anchored rating scale from 1 (not important) to 5 (very important). Of the 2484 questionnaires distributed, 2113 (85.1%) were returned. The majority of respondents considered most elements required in the ICF to be ‘moderately important’ to ‘very important’ for their decision making (mean score, ranging from 3.58 to 4.47). Major foreseeable risk, direct benefit, and common adverse effects of the intervention were considered to be of most concerned elements in the ICF (mean score = 4.47, 4.47, and 4.45, respectively). Research participants would like to be informed of the ICF elements required by ethical guidelines and regulations; however, the importance of each element varied, e.g., risk and benefit associated with research participants were considered to be more important than the general nature or technical details of research. Using a participant-oriented approach by providing more details of the participant-interested elements while avoiding unnecessarily lengthy details of other less important elements would enhance the quality of the ICF.

17 January 2019 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
MSMahaveer Singh
Mahaveer Singh
DCDavid D. Chandy
David D. Chandy
TBTamnay Bharani
Tamnay Bharani
RMRungmei S. K. Marak
Rungmei S. K. Marak
SYSubhash Yadav
Subhash Yadav
EBEesh Bhatia
Eesh Bhatia

20 December 2013 in Journal of Intensive Care
Verified
Journal Article
Open access
PDF file
AAAfzal Azim
Afzal Azim
AAArmin Ahmed
Armin Ahmed
SYSubhash Yadav
Subhash Yadav
ABArvind K Baronia
Arvind K Baronia
MGMohan Gurjar
Mohan Gurjar
RSRatender K Singh
Ratender K Singh
Limited studies are available on prevalence and severity of vitamin D deficiency in a critically ill population. To the best of our knowledge, this the first study of its kind in an Indian intensive care set-up. One hundred fifty-eight critically ill patients were prospectively enrolled for over 2 years. Demographic profile and clinical characteristics were noted. Blood sample for serum 25 (OH) D was collected on admission (4 ml). Serum 25 (OH) D was measured using radioimmunoassay kit. Vitamin D deficiency was labelled as insufficient (31–60 nmol/l), deficient (15–30 nmol/l) and undetectable (<15 nmol/l). Statistical tests used were t test, chi-square test and binary logistic regression. Vitamin D deficiency (<60 nmol/l) was present in 127 patients (80.4%). Twenty-six patients had (20.47%) undetectable vitamin D levels. The mean vitamin D level was higher amongst survivors (43.17 + 39.22) than in non-survivors (39.72 + 29.31). Vitamin D was not significantly associated with mortality in univariate analysis. Multiple logistic regression showed admission APACHE II (p = 0.008), lactate (p = 0.013) and pre-ICU hospital stay (p = 0.041) as independent predictors of mortality in critically ill patients (p < 0.05). Vitamin D deficiency is highly prevalent in critically ill patients. A causal association between vitamin D deficiency and mortality was not found in our study. Larger studies are needed to understand the relationship between vitamin D deficiency and ICU outcome.

27 July 2016 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
Narayan PrasadNarayan Prasad
Narayan Prasad
AJAkhilesh Jaiswal
Akhilesh Jaiswal
VAVikas Agarwal
Vikas Agarwal
SKShashi Kumar
Shashi Kumar
SCSaurabh Chaturvedi
Saurabh Chaturvedi
AKAnupama Kaul
Anupama Kaul
We aimed to longitudinally analyse changes in the levels of serum fibroblast growth factor 23 (FGF23), intact parathyroid hormone (iPTH) and associated minerals in patients undergoing renal transplantation. Sixty-three patients with end-stage renal disease (ESRD) who underwent living donor transplantation were recruited. Serum FGF23, iPTH, uric acid, inorganic phosphorous (iP), blood urea nitrogen and serum creatinine were measured pre-transplant and at 1 (M1), 3 (M3) and 12 months (M12) post-transplantation. FGF23 levels were decreased at M1, M3 and M12 by 93.81, 96.74 and 97.53%, respectively. iPTH levels were decreased by 67.95, 74.95 and 84.9%, respectively. The prevalence of hyperparathyroidism at M1, M3 and M12 post-transplantation was 63.5, 42.9 and 11.1%, respectively. FGF23 and iP levels remained above the normal range in 23 (36.5%) and 17 (27%) patients at M1, 10 (15.9%) and 5 (8%) at M3 and in none at M12 post-transplantation, respectively. A multivariate regression model revealed that, pre-transplant, iP was positively associated with iPTH (P = 0.016) but not with FGF 23; however, post-transplant, iP level was negatively associated with FGF23 (P < 0.001) but not with iPTH. Post-transplant FGF23 levels settle faster than those of iPTH. However, 11% of patients continued to have hyperparathyroidism even after 12 months.